Neurology

A lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.

The grant from the National Multiple Sclerosis Society aims to support the development of a potential oral treatment for progressive forms of MS.

Several drugs are in the pipeline for the treatment of specialty conditions, including cancer and multiple sclerosis.

Top news of the day from across the health care landscape.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

Top news of the day from across the health care landscape.

The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.

New classes of multiple sclerosis medications are improving on disease suppression.

Mice treated prophylactically were protected from developing multiple sclerosis and neurological deficits.

Inhibiting cytokines could prevent disease progression among those with multiple sclerosis.

An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.

Findings further strengthen the need to protect young people from head injury.

Dietary studies for patients with multiple sclerosis have centered on vitamin D and obesity, but not overall diets.

Fingolimod may reduce relapses more effectively than interferon beta-1a in pediatric multiple sclerosis.

Cladribine tablets demonstrated sustained clinical efficacy for up to 4 years treating multiple sclerosis.

Newly launched mobile research study uses real-time data collection in MS.

Risk of death from MS higher among men in military across 3 successive decades.

Legislative investigation seeks information from 7 drug makers on costs for MS medications.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.

A gut microbe may play a role in the treatment of multiple sclerosis in the future.

Upper respiratory infections cause immune cells to travel to the brain, prompting multiple sclerosis to relapse.

Physical training further minimizes brain shrinkage in MS patients already receiving medication.

New treatments for inflammatory conditions, cancer, and HIV are on the horizon. 

Potential treatment for primary progressive multiple sclerosis is an oral pill consisting of pharmaceutical formulations of purified THC and CBD.